
New Delhi, Nov. 19 -- Kotak Mahindra Asset Management Company (KMAMC/Kotak Mutual Fund) has launched the Kotak Nifty Pharma Index Fund, an open-ended scheme tracking the Nifty Pharma Index.
The NFO opened on November 16, 2026, and will close on November 30, 2026. The scheme will reopen for continuous sale & repurchase on or before December 8, 2026.
The index comprises 20 NSE-listed pharmaceutical & biotechnology companies and is rebalanced semi-annually.
Nilesh Shah, Managing Director, KMAMC, said India's pharmaceutical industry was evolving beyond generics manufacturing into a diversified global healthcare player, supported by investments in R&D, complex generics, biosimilars and specialty medicines.
Satish Dondapati, Fund Manager, KMAMC, said the fund would provide exposure to a diversified basket of pharmaceutical companies through a transparent, rules-based passive investment strategy. Investors can invest a minimum of Rs 1,000 during the NFO and any amount thereafter, subject to the scheme's terms and conditions.
Published by HT Digital Content Services with permission from Millennium Post.